GeneDx Holdings Corp.
$69.71
▲
1.04%
2026-04-21 10:15:02
www.genedx.com
NMS: WGS
Explore GeneDx Holdings Corp. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$1.92 B
Current Price
$69.71
52W High / Low
$170.87 / $55.17
Stock P/E
—
Book Value
$10.54
Dividend Yield
—
ROCE
-3.15%
ROE
-7.6%
Face Value
—
EPS
$-0.73
Exp Qtr EPS
—
Sector
Healthcare
Industry
Diagnostics & Research
Employees
1,300
Beta
2.19
Debt / Equity
36.72
Current Ratio
2.46
Quick Ratio
2.34
Forward P/E
28.98
Price / Sales
4.08
Enterprise Value
$1.69 B
EV / EBITDA
133.42
EV / Revenue
3.95
Rating
Strong Buy
Target Price
$148.89
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | GRAIL, Inc. | $51.2 | — | $2.1 B | — | -18.79% | -16.07% | $118.84 / $25.56 | $63.92 |
| 2. | Illumina, Inc. | $131.09 | 24.09 | $19.95 B | — | 16.15% | 33.36% | $155.53 / $69.83 | $17.8 |
| 3. | BillionToOne, Inc. | $86.97 | 489.81 | $3.65 B | — | 2.74% | 2.3% | $138.7 / $61.96 | $10.48 |
| 4. | Thermo Fisher Scientific Inc. | $521.21 | 29.42 | $194.29 B | 0.36% | 8.52% | 13.02% | $643.99 / $385.46 | $141.96 |
| 5. | Waters Corporation | $332.95 | 30.93 | $32.76 B | — | 20.92% | 29.28% | $414.15 / $275.05 | $43.01 |
| 6. | FONAR Corporation | $18.8 | 15.61 | $117.93 M | — | 5.81% | 6.01% | $18.86 / $12 | $27.01 |
| 7. | Inotiv, Inc. | $0.29 | — | $9.46 M | — | -17.26% | -49.76% | $3.32 / $0.22 | $3.17 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 120.99 M | 116.74 M | 102.69 M | 87.11 M | 95.64 M | — |
| Operating Profit | -14.23 M | -3.25 M | 8.96 M | -4.55 M | 8.81 M | — |
| Net Profit | -17.67 M | -7.63 M | 10.81 M | -6.53 M | 5.44 M | — |
| EPS in Rs | -0.6 | -0.26 | 0.37 | -0.22 | 0.19 | -0.31 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 427.54 M | 305.45 M | 202.57 M | 234.69 M |
| Operating Profit | -13.08 M | -23.21 M | -170.19 M | -457.51 M |
| Net Profit | -21.02 M | -52.29 M | -175.77 M | -548.98 M |
| EPS in Rs | -0.72 | -1.79 | -6 | -18.74 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 523.71 M | 419.38 M | 418.76 M | 490.94 M |
| Total Liabilities | 215.53 M | 174.13 M | 190.74 M | 237.24 M |
| Equity | 308.18 M | 245.25 M | 228.02 M | 253.71 M |
| Current Assets | 268.29 M | 197.97 M | 182.34 M | 212.62 M |
| Current Liabilities | 108.91 M | 54.82 M | 58.82 M | 144.3 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 33.28 M | -28.5 M | -180.15 M | -319.15 M |
| Investing CF | -61.52 M | -30.13 M | -43.73 M | -141.33 M |
| Financing CF | 48.02 M | 44.16 M | 186.24 M | 197.31 M |
| Free CF | 14.26 M | -33.99 M | -185.86 M | -333.48 M |
| Capex | -19.02 M | -5.49 M | -5.71 M | -14.32 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 50.79% | -13.69% | — | — |
| Earnings Growth % | 70.25% | 67.98% | — | — |
| Profit Margin % | -17.12% | -86.77% | -233.91% | — |
| Operating Margin % | -7.6% | -84.02% | -194.94% | — |
| Gross Margin % | 63.64% | 44.43% | -11.4% | — |
| EBITDA Margin % | -0.41% | -67.37% | -169.67% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
| Date | Split |
|---|---|
| 2023-05-04 | 1:0.030303 |